Evidence map›Paper›PMID 35929064›Full record

ArticleCell proliferation2022

Immune repertoire analysis of normal Chinese donors at different ages.

Cailing Song, Wenjing Pan, Brittany Brown, Congli Tang, Yunqi Huang, Houao Chen, Nan Peng, Zhe Wang, Daniel Weber, Miranda Byrne-Steele and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Cailing SongHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.ORCID https://orcid.org/0000-0002-6688-7404
Wenjing PanHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Brittany BrowniRepertoire Inc., Huntsville, Alabama, USA.
Congli TangNanjing ARP Biotechnology Co., Ltd., Nanjing, China.
Yunqi HuangHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Houao ChenHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Nan PengHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Zhe WangHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Daniel WeberiRepertoire Inc., Huntsville, Alabama, USA.
Miranda Byrne-SteeleiRepertoire Inc., Huntsville, Alabama, USA.
Haijing WuDepartment of Dermatology, Second Xiangya Hospital, Hunan Key Laboratory of Medical Epigenomics, Central South University, Changsha, China.
Hongna LiuHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Yan DengHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Nongyue HeHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Song LiHunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, China.
Hunan University of Technology · CNBeike Biotechnology (China) · CNiRepertoire (United States) · USCentral South University · CNGuangdong Academy of Medical Sciences · CN

Funding

Hunan Key R&D Projects 2021SK2003Hunan Provincial Natural Science Foundation of China 2019JJ50122Hunan Urgency Project 2020SK3005National Key R&D Program of China 2019YFE0191000National Key R&D Program of China 2021YFE0191400National Key R&D Program of China 2021YFE0200400National Natural Science Foundation of China 61871180National Natural Science Foundation of China 61971187
6 · The paper itself

Abstract

objectivesThis study investigated the characteristics of the immune repertoire in normal Chinese individuals of different ages. MATERIALS AND

methodsIn this study, all seven receptor chains from both B and T cells in peripheral blood of 16 normal Chinese individuals from two age groups were analyzed using high-throughput sequencing and dimer-avoided multiplex PCR amplification. Normal in this study is defined as no chronic, infectious or autoimmune disease within 6 months prior to blood draw.

resultsWe found that compared with the younger group, the clonal expression of T-cell receptor repertoire increased in the older group, while diversity decreased. In addition, we found that the T-cell receptor repertoire was more significantly affected by age than the B-cell receptor repertoire, including significant differences in the use of the unique TCR-alpha and TCR-beta V-J gene combinations, in the two groups of normal participants. We further analyzed the degree of complementarity determining region 3 sequence sharing between the two groups, and found shared TCR-alpha, TCR-gamma, immunoglobulin-kappa and immunoglobulin-lambda chain complementarity determining region 3 sequences in all subjects.

conclusionTaken together, our study gives us a better understanding of the immune repertoire of different normal Chinese people, and these results can be applied to the treatment of age-related diseases. Immune repertoire analysis also allows us to observe participant's wellness, aiding in early-stage diagnosis.

Indexed as

Complementarity Determining RegionsReceptors, Antigen, T-Cell, alpha-betaChinaHigh-Throughput Nucleotide SequencingHumansT-LymphocytesComplementarity Determining RegionsReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID35929064
PMCPMC9628227
OpenAlexW4289943573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.